Liver MR Imaging: 1.5T versus 3T

Magnetic Resonance Imaging Clinics of North America

Volumn 15, Issue 3, 2007, Pages 321-347

  Ramalho, Miguel ^a   Altun, Ersan ^a   Herédia, Vasco ^a   Zapparoli, Mauricio ^a   Semelka, Richard ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ARTIFACT; BILE DUCT DISEASE; CHRONIC HEPATITIS; FATTY LIVER; HAMARTOMA; HEMOCHROMATOSIS; HUMAN; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER CYST; LIVER DISEASE; LIVER METASTASIS; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SIGNAL NOISE RATIO;

ARTIFACTS; CONTRAST MEDIA; ECHO-PLANAR IMAGING; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING;

EID: 34548759050     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2007.06.003     Document Type: Review

References (63)

1. Stanisz G.J., Odrobina E.E., Pun J., et al. T1, T2 relaxation and magnetization transfer in tissue at 3.0T. Magn Reson Med 54 (2005) 507-512
2. de Bazelaire C.M., Duhamel G.D., Rofsky N.M., et al. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230 (2004) 652-659
3. Merkle E.M., and Dale B.M. Abdominal MRI at 3.0 T: the basics revisited. AJR Am J Roentgenol 186 (2006) 1524-1532
4. Morakkabati-Spitz N., Gieseke J., Kuhl C., et al. 3.0-T high-field magnetic resonance imaging of the female pelvis: preliminary experiences. Eur J Radiol 15 (2005) 639-644
5. Gibbs G.F., Huston III J., Bernstein M.A., et al. Improved image quality of intracranial aneurysms: 3.0-T versus 1.5-T time-of-flight MR angiography. AJNR Am J Neuroradiol 25 (2004) 84-87
6. Leiner T., de Vries M., Hoogeveen R., et al. Contrast-enhanced peripheral MR angiography at 3.0 Tesla: initial experience with a whole-body scanner in healthy volunteers. J Magn Reson Imaging 17 (2003) 609-614
7. Allkemper T., Tombach B., Schwindt W., et al. Acute and subacute intracerebral hemorrhages: comparison of MR imaging at 1.5 and 3.0 T: initial experience. Radiology 232 (2004) 874-881
8. Frayne R., Goodyear B.G., Dickhoff P., et al. Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38 (2003) 385-402
9. Lenk S., Ludescher B., Martirosan P., et al. 3.0 T high-resolution MR imaging of carpal ligaments and TFCC. Rofo 176 (2004) 664-667
10. Eckstein F., Charles H.C., Buck R.J., et al. Accuracy and precision of quantitative assessment of cartilage morphology by magnetic resonance imaging at 3.0T. Arthritis Rheum 52 (2005) 3132-3136
11. Kornaat P.R., Reeder S.B., Koos S., et al. MR imaging of articular cartilage at 1.5T and 3.0T: comparison of SPGR and SSFP sequences. Osteoarthritis Cartilage 13 (2005) 338-344
12. Hussain S.M., Wielopolski P.A., and Martin D.R. Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future?. Top Magn Reson Imaging 16 (2005) 325-335
13. von Falkenhausen M.M., Lutterbey G., Morakkabati-Spitz N., et al. High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T. Radiology 241 (2006) 156-166
14. Diego R., Martin D.R., Friel H.T., et al. Approach to abdominal imaging at 1.5 tesla and optimization at 3 tesla. Magn Reson Imaging Clin N Am 16 (2005) 241-254
15. Schindera S.T., Merkle E.M., Dale B.M., et al. Abdominal magnetic resonance imaging at 3.0 T: what is the ultimate gain in signal-to-noise ratio?. Acad Radiol 13 (2006) 1236-1243
16. Merkle E., Dale B.M., and Paulson E.K. Abdominal MR imaging at 3.0T. Magn Reson Imaging Clin N Am 14 (2006) 17-26
17. Gaa J., Hutabu H., Jenkins R.L., et al. Liver masses: replacement of conventional T2-weighted spin echo MR imaging with breath-hold MR imaging. Radiology 200 (1996) 459-464
18. De Lange E.E., Mugler III J.P., Bosworth J.E., et al. MR imaging of the liver: breath-hold T1-weighted MP-GRE compared with conventional T2-weighted SE imaging-lesion detection, localization, and characterization. Radiology 190 (1994) 727-736
19. Kanematsu M., Semelka R., Matsuo M., et al. Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases-a prospective randomized study in patients with chronic liver damage. Radiology 225 (2002) 407-415
20. Martin D.R., and Semelka R.C. Magnetic resonance imaging of the liver: review of techniques and approach to common diseases. Semin Ultrasound CT MR 26 (2005) 116-131
21. Rofsky N.M., Lee V.S., Laub G., et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212 (1999) 876-884
22. Balci N.C., and Semelka R.C. Contrast agents for MR imaging of the liver. Radiol Clin North Am 43 (2005) 887-898
23. Semelka R.C., and Helmberger T.K. Contrast agents for MR imaging of the liver. Radiology 218 (2001) 27-38
24. Shamsi K. Gd-EOB-DTPA, a liver-specific contrast agent for MRI: results of a placebo controlled, double blind dose ranging study in patients with focal liver lesions. Presented at the 10th Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine. Honolulu, Hawaii, May 18-24, 2002.
25. Grazioli L., Morana G., Kirchin M.A., et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236 (2005) 166-177
26. Lim J.S., Kim M.-J., Jung Y.Y., et al. Gadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction. Korean J Radiol 6 (2005) 229-234
27. Nitz W.R. SAR reduction (GRAPPA). In: Runge V.M., Nitz W.R., Schmeets S.H., et al. (Eds). Clinical 3T magnetic resonance. 1st edition (2007), Thieme, New York 34-35
28. Pruessmann K.P. Parallel imaging at high field strength: synergies and joint potential. Top Magn Reson Imaging 15 (2004) 237-244
29. Glockner J.F., Hu H.H., Stanley D.W., et al. Parallel MR imaging: a user's guide. Radiographics 25 (2005) 1279-1297
30. Tanenbaum L.N. Clinical 3T MR imaging: mastering the challenges. Magn Reson Imaging Clin N Am 14 (2006) 1-15
31. Hargreaves B.A., Cunningham C.H., Nishimura D.G., et al. Variable-rate selective excitation for rapid MRI sequences. Magn Reson Med 52 (2004) 590-597
32. Hennig J., Weigel M., and Scheffler K. Multiecho sequences with variable refocusing flip angles: optimization of signal behavior using smooth transitions between pseudo steady states (TRAPS). Magn Reson Med 49 (2003) 527-535
33. Bernstein M.A., Huston III J., and Ward H.A. Imaging artifacts at 3.0T. Magn Reson Imaging 24 (2006) 735-746
34. Sreenivas M., Lowry M., Gibbs P., et al. A simple solution for reducing artefacts due to conductive and dielectric effects in clinical magnetic resonance imaging at 3 T. Eur J Radiol 62 (2007) 143-146
35. Sasaki M., Shibata E., Kanbara Y., et al. Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 T versus 3 Tesla: a phantom study. Magn Reson Med Sci 4 (2005) 145-149
36. Nobauer-Huhmann I.M., Ba-Ssalamah A., Mlynarik V., et al. Magnetic resonance imaging contrast enhancement of brain tumors at 3 tesla versus 1.5 tesla. Invest Radiol 37 (2002) 114-119
37. Farrell G., and Larter C. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
38. Gholam P.M., Flancbaum L., Machan J.T., et al. Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol 102 (2007) 399-408
39. Harrison S.A., and Neuschwander-Tetri B.A. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 8 (2004) 871-879
40. Mitchell D.G. Focal manifestations of diffuse liver disease at MR imaging. Radiology 185 (1992) 1-11
41. Alústiza J.M., Artetxe J., Castiella A., et al. MR quantification of hepatic iron concentration. Radiology 230 (2004) 479-484
42. Kanematsu M., Semelka R.C., Leonardou P., et al. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. J Magn Reson Imaging 18 (2003) 189-195
43. Krinsky G.A., and Lee V.S. MR imaging of cirrhotic nodules. Abdom Imaging 25 (2000) 471-482
44. Martin D.R., and Semelka R.C. Imaging of benign and malignant focal liver lesions. Magn Reson Imaging Clin N Am 9 VI-VII (2001) 785-802
45. Winston C.B., Schwartz L.H., Fong Y., et al. Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology 210 (1999) 75-79
46. Kelekis N.L., Semelka R.C., Woawattanakul S., et al. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2 weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 170 (1998) 1005-1013
47. Bruneton J.N., Raffaelli C., Maestro C., et al. Benign liver lesions: implications of detection in cancer patients. Eur Radiol 5 (1995) 387-390
48. Shoenut J.P., Semelka R.C., Levi C., et al. Ciliated hepatic foregut cysts: US, CT, and contrast-enhanced MR imaging. Abdom Imaging 19 (1994) 150-152
49. Chung E.B. Multiple bile-duct hamartomas. Cancer 26 (1970) 287-296
50. Semelka R.C., Hussain S.M., Marcos H.B., et al. Biliary hamartomas: solitary and multiple lesions shown on current MR techniques including gadolinium enhancement. J Magn Reson Imaging 10 (1999) 196-201
51. Craig J, Peters R, Edmonson H. Tumors of the liver and intrahepatic bile ducts. In: Hartman H, Sobin L, editors. Atlas of tumor pathology. 2nd edition. Washington, DC: Armed Forces Institute of Pathology.
52. Karhunen P.J. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39 (1986) 183-188
53. Semelka R.C., Brown E.D., Ascher S.M., et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 192 (1994) 401-406
54. Danet I.M., Semelka R.C., Braga L., et al. Giant cavernous hemangioma of the liver: MR imaging characteristics in 24 patients. Magn Reson Imaging 21 (2003) 95-101
55. Semelka R.C., Worawattenakul S., Noone K., et al. Chemotherapy-treated liver metastases mimicking hemangiomas on MR images. Abdom Imaging 24 (1999) 378-382
56. Vilgrain V. Focal nodular hyperplasia. Eur J Radiol 58 (2006) 236-245
57. Stanley G., Jeffrey R.B., and Feliz B. CT findings and histopathology of intratumoral steatosis in focal nodular hyperplasia: case report and review of the literature. J Comput Assist Tomogr 26 (2002) 815-817
58. Mortele K.J., Praet M., van Vlierberghe H., et al. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol 175 (2000) 687-692
59. Wiener Y., Dushnitzky T., Slutzki S., et al. Synchronous bleeding of liver adenomatosis and possible relation to acoustic trauma. HPB Surg 3 (2001) 267-269
60. Chiche L., Dao T., Salame E., et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 231 (2000) 74-81
61. Evlampia A., Psatha E.A., Semelka R.C., et al. Hepatocellular adenomas in men: MRI findings in four patients. J Magn Reson Imaging 22 (2005) 258-264
62. Foster J.H., and Berman M.M. The malignant transformation of liver cell adenomas. Arch Surg 129 (1994) 712-717
63. Paulson E.K., McClellan J.S., Washington K., et al. Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 163 (1994) 113-116